Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
Loading...
Date
2021
Authors
Vrede, S. W.
Van Weelden, Willem Jan
Visser, N. C. M.
Bulten, Johan
van der Putten, Louis J. M.
van de Vijver, Koen
Santacana Espasa, Maria
Gil-Moreno, Antonio
Moiola, Cristian P.
Other authors
Impact
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Gynecologic Oncology, 2021, vol. 161, núm. 3, p. 787-794